For Immediate Release: February 27, 2021
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States, said Acting FDA Commissioner Janet Woodcock, M.D. The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccines with the urgency called for during this pandemic, using the agencys rigorous standards for safety, effectiveness and manufacturing quality needed to support emergency use authorization.
The FDA has determined that the Janssen COVID-19 Vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data provides clear evidence that the Janssen COVID-19 Vaccine may be effective in preventing COVID-19. The data also show that the vaccines known and potential benefits outweigh its known and potential risks, supporting the companys request for the vaccines use in people 18 years of age and older. In making this determination, the FDA can assure the public and medical community that it has conducted a thorough evaluation of the available safety, effectiveness and manufacturing quality information.
The Janssen COVID-19 Vaccine is manufactured using a specific type of virus called adenovirus type 26 (Ad26). The vaccine uses Ad26 to deliver a piece of the DNA, or genetic material, that is used to make the distinctive spike protein of the SARS-CoV-2 virus. While adenoviruses are a group of viruses that are relatively common, Ad26, which can cause cold symptoms and pink eye, has been modified for the vaccine so that it cannot replicate in the human body to cause illness. After a person receives this vaccine, the body can temporarily make the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2.
After a thorough analysis of the data, the FDAs scientists and physicians have determined that the vaccine meets the FDAs expectations for safety and effectiveness appropriate for the authorization of a vaccine for emergency use, said Peter Marks, M.D., Ph.D., director of the FDAs Center for Biologics Evaluation and Research. With todays authorization, we are adding another vaccine in our medical toolbox to fight this virus. At the same time, the American people can be assured of the FDAs unwavering commitment to public health through our comprehensive and rigorous evaluation of the data submitted for vaccines to prevent COVID-19.
FDA Evaluation of Available Safety Data
The Janssen COVID-19 Vaccine is administered as a single dose. The available safety data to support the EUA include an analysis of 43,783 participants enrolled in an ongoing randomized, placebo-controlled study being conducted in South Africa, certain countries in South America, Mexico, and the U.S. The participants, 21,895 of whom received the vaccine and 21,888 of whom received saline placebo, were followed for a median of eight weeks after vaccination. The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects were mild to moderate in severity and lasted 1-2 days.
As part of the authorization, the FDA notes that it is mandatory for Janssen Biotech Inc. and vaccination providers to report the following to the Vaccine Adverse Event Reporting System (VAERS) for Janssen COVID-19 Vaccine: serious adverse events, cases of Multisystem Inflammatory Syndrome and cases of COVID-19 that result in hospitalization or death.
It is also mandatory for vaccination providers to report all vaccine administration errors to VAERS for which they become aware and for Janssen Biotech Inc. to include a summary and analysis of all identified vaccine administration errors in monthly safety reports submitted to the FDA.
FDA Evaluation of Available Effectiveness Data
The effectiveness data to support the EUA include an analysis of 39,321 participants in the ongoing randomized, placebo-controlled study being conducted in South Africa, certain countries in South America, Mexico, and the U.S. who did not have evidence of SARS-CoV-2 infection prior to receiving the vaccine. Among these participants, 19,630 received the vaccine and 19,691 received saline placebo. Overall, the vaccine was approximately 67% effective in preventing moderate to severe/critical COVID-19 occurring at least 14 days after vaccination and 66% effective in preventing moderate to severe/critical COVID-19 occurring at least 28 days after vaccination.
Additionally, the vaccine was approximately 77% effective in preventing severe/critical COVID-19 occurring at least 14 days after vaccination and 85% effective in preventing severe/critical COVID-19 occurring at least 28 days after vaccination.
There were 116 cases of COVID-19 in the vaccine group that occurred at least 14 days after vaccination, and 348 cases of COVID-19 in the placebo group during this time period. There were 66 cases of COVID-19 in the vaccine group that occurred at least 28 days after vaccination and 193 cases of COVID-19 in the placebo group during this time period. Starting 14 days after vaccination, there were 14 severe/critical cases in the vaccinated group versus 60 in the placebo group, and starting 28 days after vaccination, there were 5 severe/critical in the vaccine group versus 34 cases in the placebo group.
At this time, data are not available to determine how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person.
The EUA Process
On the basis of the determination by the Secretary of the Department of Health and Human Services on Feb. 4, 2020, that there is a public health emergency that has a significant potential to affect national security or the health and security of United States citizens living abroad, and issued declarations that circumstances exist justifying the authorization of emergency use of unapproved products, the FDA may issue an EUA to allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent COVID-19 when there are no adequate, approved, and available alternatives.
The issuance of an EUA is different than an FDA approval (licensure) of a vaccine, in that a vaccine available under an EUA is not approved. In determining whether to issue an EUA for a product, the FDA evaluates the available evidence to determine whether the product may be effective and also assesses any known or potential risks and any known or potential benefits If the product meets the effectiveness standard and the benefit-risk assessment is favorable, the product is made available during the emergency. Once a manufacturer submits an EUA request for a COVID-19 vaccine to the FDA, the agency then evaluates the request and determines whether the relevant statutory criteria are met, taking into account the totality of the scientific evidence about the vaccine that is available to the FDA.
The EUA also requires that fact sheets that provide important information, including dosing instructions, and information about the benefits and risks of the Janssen COVID-19 Vaccine, be made available to vaccination providers and vaccine recipients.
Janssen Biotech Inc. has submitted a pharmacovigilance plan to the FDA describing its commitment to monitor the safety of Janssen COVID-19 Vaccine. The pharmacovigilance plan includes a plan to complete longer-term safety follow-up for participants enrolled in ongoing clinical trials. The pharmacovigilance plan also includes other activities aimed at monitoring the safety profile of the Janssen COVID-19 Vaccine and ensuring that any safety concerns are identified and evaluated in a timely manner.
The FDA also expects manufacturers whose COVID-19 vaccines are authorized under an EUA to continue their clinical trials to obtain additional safety and effectiveness information and pursue approval (licensure).
The EUA for the Janssen COVID-19 Vaccine was issued to Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. The authorization will be effective until the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biologics for prevention and treatment of COVID-19 is terminated. The EUA for Janssen COVID-19 Vaccine may be revised or revoked if it is determined the EUA no longer meets the statutory criteria for issuance.
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine - FDA.gov
- Coronavirus news live: Latest as lockdown easing sees shops and pubs crowded - The Independent - April 12th, 2021
- Covid UK: coronavirus cases, deaths and vaccinations today - The Guardian - April 12th, 2021
- Asia Today: India records another surge in COVID-19 cases - The Associated Press - April 12th, 2021
- The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New... - April 12th, 2021
- How Long Should You Wait To Get the Vaccine After Having COVID-19? - ideastream - April 9th, 2021
- What you should (and shouldn't) do with your vaccination card - KING5.com - April 9th, 2021
- UC Davis Health opening vaccinations up to anyone 16 and older | COVID-19 Updates in Northern California - ABC10.com KXTV - April 7th, 2021
- Can Vaccinated People Spread the Virus? - The New York Times - April 5th, 2021
- Germany to restrict AstraZeneca use in under-60s over clots - The Associated Press - April 5th, 2021
- The COVID-19 vaccine side effects you can expect based on your age, sex, and dose - Business Insider - April 5th, 2021
- Covid-19: Johnson & Johnson Put in Charge of Plant That Ruined Millions of Vaccine Doses - The New York Times - April 5th, 2021
- Germany restricts use of AstraZeneca vaccine to over 60s in most cases - DW (English) - April 5th, 2021
- Coronavirus vaccines with a side of fried fish are on the Good Friday menu in Central City - NOLA.com - April 3rd, 2021
- Explained: Making sense of Indias Covid-19 data - The Indian Express - April 3rd, 2021
- 35 Pa. counties have substantial spread of COVID-19; positive test rate rises for second week in a row - PennLive - March 30th, 2021
- Covid-19 News: In-Person School Attendance Inches Up but Roadblocks Remain - The New York Times - March 30th, 2021
- COVID-19 cases surging in Pa. and N.J. as variants spread; Biden sets goal of 200 million vaccinations by end - The Philadelphia Inquirer - March 28th, 2021
- Why Supply Isnt the Only Thing Stymying Europes Coronavirus Vaccine Rollout - The New York Times - March 26th, 2021
- All Georgia adults will be eligible for coronavirus vaccines starting Thursday - Atlanta Journal Constitution - March 26th, 2021
- COVID Vaccine (COVID-19 Immunization Updates) | CVS Pharmacy - March 24th, 2021
- Mavericks won't require their players to get the coronavirus vaccine - The Official Home of the - Mavs.com - March 24th, 2021
- Health experts give green light to Janssen COVID jab, allay clotting concerns - UN News - March 20th, 2021
- New York City marks anniversary of 1st COVID-19 death with memorial services - ABC News - March 15th, 2021
- Will I have to wear a mask after getting the Covid vaccine? The science explained - The Guardian - March 15th, 2021
- Health Department ignored red flags in Philly Fighting COVID partnership, inspector general says - The Philadelphia Inquirer - March 11th, 2021
- Coronavirus vaccination scam calls reported in Bay and Saginaw counties - MLive.com - March 11th, 2021
- When will children be able to get COVID-19 vaccines? - KHOU.com - March 8th, 2021
- What you need to know about the new Johnson & Johnson vaccine - WHYY - March 8th, 2021
- People who have had COVID-19 might need only one shot of a coronavirus vaccine - Science News Magazine - March 6th, 2021
- "Corona Virus Vaccine Market Size is Projected to reach 75.75 Billion by end of 2021, Says Brandessence Market Research" - PR Newswire India - March 6th, 2021
- Who should skip the second shot of coronavirus vaccine? Weve got answers - cleveland.com - March 4th, 2021
- Explained: As you take the Covid-19 vaccine, some dos and donts - The Indian Express - March 4th, 2021
- "Corona Virus Vaccine Market Size is Projected to reach 75.75 Billion by end of 2021, Says Brandessence Market Research" USA - PRNewswire - March 4th, 2021
- Indias Covid-19 Vaccine Is Found Effective, Boosting National Efforts - The Wall Street Journal - March 4th, 2021
- Latest COVID-19 vaccination numbers in DC, Maryland and Virginia - WTOP - March 4th, 2021
- Situation Update: Response to COVID-19 in Indonesia (As of 1 March 2021) [EN/ID] - Indonesia - ReliefWeb - March 4th, 2021
- Dietary Supplement Use and COVID-19: What You Need to Know - JD Supra - March 4th, 2021
- Texas is diverting thousands of COVID-19 vaccine doses away from Dallas County, Judge Jenkins says - WFAA.com - March 2nd, 2021
- The latest on the coronavirus pandemic and vaccines: Live updated - CNN - March 2nd, 2021
- Coronavirus UK news update Covid alert drops from 5 to 4 as Queen asks Brits wary of vaccine to think abo - The Sun - February 26th, 2021
- Who is next on the priority list for Covid vaccines - and how will I be contacted? - Telegraph.co.uk - February 26th, 2021
- The Covid-19 vaccines reduce transmission. Heres the evidence. - Vox.com - February 24th, 2021
- India's Covid vaccine maker told to meet domestic demand first, urges 'rest of the world' to be patient - CNBC - February 24th, 2021
- Governor Lamont Announces Connecticut Will Continue Age-Based Approach To COVID-19 Vaccine Eligibility; Educators and Childcare Providers To Have... - February 24th, 2021
- Australian Open crowd boos at mention of coronavirus vaccines and Victorian government after Novak Djokovic's win - ABC News - February 22nd, 2021
- Quixplained: What is the South African variant of Covid-19? - The Indian Express - February 20th, 2021
- Texas power outage, storm delay COVID-19 vaccine deliveries, injections - The Texas Tribune - February 20th, 2021
- How many Covid vaccinations have been given in my area? Use our postcode tool to find out - Telegraph.co.uk - February 20th, 2021
- Who is next on the priority list for Covid vaccines - and how will I be contacted? - The Telegraph - February 20th, 2021
- COVID-19 tests, not to be confused with vaccine, in LA to be available without appointment next week - FOX 11 Los Angeles - February 20th, 2021
- New coronavirus variants are emerging across the globe: Everything we know - CNET - February 18th, 2021
- Heres why some coronavirus vaccine suppliers say they arent selling to provinces - Global News - February 18th, 2021
- More Than 4 Million Doses of COVID-19 Vaccine Have Been Given in Texas; Supersites Arrive Next Week - NBC 5 Dallas-Fort Worth - February 16th, 2021
- The superspreaders behind top COVID-19 conspiracy theories - The Associated Press - February 16th, 2021
- India is set to become a vital Covid vaccine maker perhaps second only to the U.S. - CNBC - February 16th, 2021
- Oxford Covid-19 vaccine Q&A: How effective is it, and how is it different to the Pfizer vaccine? - Telegraph.co.uk - February 16th, 2021
- Boris Johnson says move to ease lockdown will be irreversible - The Independent - February 16th, 2021
- Explained: Are new Covid-19 variants detected in the US more contagious? - The Indian Express - February 16th, 2021
- 78-Year-Old Woman Dies After Receiving COVID-19 Vaccine; No Link Suspected - NBC Southern California - February 14th, 2021
- Here's Who Will Be Eligible for the COVID Vaccine in Illinois Starting Next Week - NBC Chicago - February 14th, 2021
- Coronavirus UK news LIVE Britain to hit 15m Covid vaccination target TODAY as plan to get out of lockdown l - The Sun - February 14th, 2021
- A doctor had 6 hours to use a vial of COVID-19 vaccine before it expired, so he gave the shots to 10 people. For that, he was fired. - Chicago Tribune - February 12th, 2021
- Memphis surgeon dies of COVID-related illness weeks after receiving second COVID vaccine - WREG NewsChannel 3 - February 12th, 2021
- Where to sign up for COVID-19 vaccine in Austin, Travis County area - KXAN.com - February 11th, 2021
- Pfizer and Moderna's COVID-19 vaccines are just the beginning. Will Australia miss out on the mRNA medical revolution? - ABC News - February 9th, 2021
- Covid UK news LIVE Over 70s URGED to chase coronavirus vaccine slots as Brits told too early to book summe - The Sun - February 9th, 2021
- UK coronavirus LIVE: Brits face third AstraZeneca vaccine as over-70s urged to contact NHS for jab - Evening Standard - February 9th, 2021
- LIVE BLOG: North Carolina bills for COVID-19 relief, mandatory in-person schooling working through General Assembly - WXII12 Winston-Salem - February 6th, 2021
- New COVID-19 prediction models forecast a potential fourth wave and how to minimize it - GeekWire - February 6th, 2021
- Covid UK news Most adults will be vaccinated by May leaked letter reveals as it emerged pub curfew to be s - The Sun - February 6th, 2021
- The priority list for the Covid vaccines - and how you will be contacted - Telegraph.co.uk - February 6th, 2021
- Select Texas CVS Pharmacy locations to begin administering COVID-19 vaccines next week - KXAN.com - February 4th, 2021
- The Second COVID-19 Shot Is a Rude Reawakening for Immune Cells - The Atlantic - February 4th, 2021
- You think it's taking too long for Covid vaccination? Global Vaccine Timeline stretched to 2023! - Sierra Wave - February 4th, 2021
- What to Know About Covid-19 and the 2021 Super Bowl - The New York Times - February 4th, 2021
- A Primer on the COVID-19 Vaccines Available in the United States - Davidson News - February 1st, 2021
- Go read this story about how bad software helped slow coronavirus vaccine distribution - The Verge - February 1st, 2021
- Tax season 2021: Stimulus payments, unemployment and every other major change - CNET - January 30th, 2021
- Oregon COVID-19 vaccine update: More than 300,000 people have received at least one dose - KGW.com - January 30th, 2021
- How to get the COVID-19 vaccine from Walgreens - WFLA - January 29th, 2021